Loading...
Market
What will be the financial impact of the DOJ settlement on Walgreens' Q4 2024 earnings?
2
Resolution / Starting Odds
Earnings decrease by more than 20% • 25%
Earnings decrease by 10-20% • 25%
Earnings decrease by less than 10% • 25%
No significant impact • 25%
Walgreens' Q4 2024 earnings report
Story
Walgreens to Pay $106.8 Million to Settle DOJ Prescription Billing Fraud Charges
Sep 13, 2024, 07:30 PM
Walgreens Boots Alliance has agreed to pay $106.8 million to resolve allegations that it billed the U.S. government for prescriptions that were never dispensed. The settlement addresses charges brought by the Department of Justice (DOJ) under the False Claims Act. The allegations cover a period between 2009 and 2020, during which Walgreens is accused of improperly billing government health care programs, including Medicare, involving fraudulent activities.
View original story
Similar markets
Revenue increases by more than 5% • 25%
Revenue remains stable (±5%) • 25%
Revenue decreases by up to 5% • 25%
Revenue decreases by more than 5% • 25%
Increase by more than 5% • 25%
Decrease by more than 5% • 25%
No significant change • 25%
Other • 25%
Increase in earnings • 25%
Decrease in earnings • 25%
No significant change • 25%
Other • 25%
No significant impact • 25%
Minor financial penalties • 25%
Major financial penalties • 25%
Severe financial penalties • 25%
Less than $0.30 • 25%
$0.30 to $0.39 • 25%
$0.40 to $0.49 • 25%
More than $0.49 • 25%
No penalty • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Revenue increases • 25%
Revenue decreases • 25%
Net income increases • 25%
Net income decreases • 25%
